Skip to content
10-Q

Quarterly Report

NewAmsterdam Pharma Company N.V. NAMS NAMSW

0000950170-25-103521

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 112.63M sh
Shares Diluted Q2 2025 · Jun 30, 2025 118.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 117.35M sh
Shares Diluted Q2 2025 · Jun 30, 2024 94.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 91.61M sh
Capex Q2 2025 · Jun 30, 2025 $104K
Capex Q2 2025 · Jun 30, 2024 $594K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$74.14M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$108.58M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $563.86M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $771.74M
Stockholders Equity Q2 2025 · Jun 30, 2025 $778.5M
Stockholders Equity Q2 2025 · Mar 31, 2025 $777.36M
Stockholders Equity Q2 2025 · Dec 31, 2024 $757.5M
Stockholders Equity Q2 2025 · Jun 30, 2024 $387.44M
Stockholders Equity Q2 2025 · Mar 31, 2024 $411.8M
Stockholders Equity Q2 2025 · Dec 31, 2023 $288.39M
Current Liabilities Q2 2025 · Jun 30, 2025 $36.51M
Current Liabilities Q2 2025 · Dec 31, 2024 $106.92M
Total Liabilities Q2 2025 · Jun 30, 2025 $36.62M
Total Liabilities Q2 2025 · Dec 31, 2024 $107.12M
Current Assets Q2 2025 · Jun 30, 2025 $769.85M
Current Assets Q2 2025 · Dec 31, 2024 $863.41M
Total Assets Q2 2025 · Jun 30, 2025 $815.11M
Total Assets Q2 2025 · Dec 31, 2024 $864.62M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.48
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.41
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.45
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.48
Eps Basic Q2 2025 · Jun 30, 2024 −$0.41
Eps Basic Q2 2025 · Jun 30, 2024 −$1.45
Sga Expense Q2 2025 · Jun 30, 2025 $27.26M
Sga Expense Q2 2025 · Jun 30, 2025 $54.42M
Sga Expense Q2 2025 · Jun 30, 2024 $16.48M
Sga Expense Q2 2025 · Jun 30, 2024 $30.93M
Rd Expense Q2 2025 · Jun 30, 2025 $27.52M
Rd Expense Q2 2025 · Jun 30, 2025 $72.27M
Rd Expense Q2 2025 · Jun 30, 2024 $38.38M
Rd Expense Q2 2025 · Jun 30, 2024 $80.81M
Net Income Q2 2025 · Jun 30, 2025 −$17.36M
Net Income Q2 2025 · Jun 30, 2025 −$56.89M
Net Income Q2 2025 · Jun 30, 2024 −$39.01M
Net Income Q2 2025 · Jun 30, 2024 −$132.77M
Operating Income Q2 2025 · Jun 30, 2025 −$35.64M
Operating Income Q2 2025 · Jun 30, 2025 −$104.56M
Operating Income Q2 2025 · Jun 30, 2024 −$52.58M
Operating Income Q2 2025 · Jun 30, 2024 −$108.06M
Revenue Q2 2025 · Jun 30, 2025 $19.15M
Revenue Q2 2025 · Jun 30, 2025 $22.12M
Revenue Q2 2025 · Jun 30, 2024 $2.28M
Revenue Q2 2025 · Jun 30, 2024 $3.68M